EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudie

Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study

Wen Guo, Yan Sun, Yimin Yin, Fei Lin, Dan Liu, Jin Xu, Chengxiao Yu, Zhenzhen Fu, Yingyun Gong, Qun Zhang, Hongwen Zhou

Nutrition, Metabolism and Cardiovascular Diseases · 2026

DOI: 10.1016/j.numecd.2026.104850 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026. Verfasst von Wen Guo und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Hauptthemen laut MEDLINE: Lipoprotein(a), Carotid Artery Diseases, Non-alcoholic Fatty Liver Disease. Die Arbeit nennt 30 Literaturangaben. Gefördert von: National Science and Technology Major Project, Nanjing Medical University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND AIM: This study investigated the associations of Lipoprotein (a) [Lp(a)] and metabolic dysfunction-associated steatotic liver disease (MASLD) with carotid atherosclerosis (CAS) risk, both independently and in combination. METHODS AND RESULTS: We performed a multicenter cross-sectional study in participants without cardiovascular disease (CVD) (study 1, n = 61,139) and a longitudinal study in participants without CVD and CAS at baseline who underwent at least two health check-up exams with carotid ultrasound (study 2, n = 9720). Hepatic steatosis and liver fibrosis were assessed via abdominal ultrasonography and the fibrosis-4 (FIB-4) index, respectively. In study 1, among participants without MASLD, those with elevated Lp(a) (≥30 mg/dL) had a significantly higher risk of CAS as compared to those with Lp(a) < 30 mg/dL. During a median follow-up of 33 months in Study 2, 2309 (23.76%) of 9720 participants progressed to CAS. Baseline Lp(a) ≥30 mg/dL (adjusted HR = 1.67, 95% CI 1.52-1.83, P < 0.001) and MASLD (adjusted HR = 1.21, 95% CI 1.09-1.33, P < 0.001) were independent risk factors for CAS. In the stratified analysis, a joint effect of Lp(a) ≥30 mg/dL and MASLD on CAS risk was observed. Those with Lp(a) (≥30 mg/dL) and MASLD had a HR (95% CI) of 2.07 (1.76-2.43, P < 0.001) compared to those with Lp(a) < 30 mg/dL without MASLD, but there was no interaction (Pinteraction = 0.453). Meanwhile, the risk of CAS in participants with Lp(a) ≥30 mg/dL and FIB-4 ≥1.3 was 2.62 times higher than Lp(a) < 30 mg/dL and FIB-4

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lipoprotein(a)Carotid Artery DiseasesNon-alcoholic Fatty Liver DiseaseHumansCross-Sectional StudiesMaleFemaleMiddle AgedLongitudinal StudiesRisk FactorsBiomarkersAgedAsymptomatic DiseasesTime FactorsUltrasonography, Carotid ArteriesAdultPredictive Value of TestsRisk AssessmentUp-RegulationDisease ProgressionPrognosisLiver Cirrhosis

Stichwörter der Autor:innen

Carotid atherosclerosisLipoprotein (a)Metabolic dysfunction-associated steatotic liver diseasePrimary prevention

Substanzen

Lipoprotein(a)BiomarkersLPA protein, human

Autor:innen und Institutionen

  • Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China.
  • Department of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China.
  • School of Public Health, Nanjing Medical University, Nanjing, 211166, China.
  • Department of Health Management Center, The First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
  • Department of Endocrinology and Metabolism, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Electronic address: gongyingyun@126.com.
  • Department of Health Promotion Center, The First Affiliated Hospital with Nanjing Medical University, Nanjing, 210029, China. Electronic address: lucyqzhang@njmu.edu.cn.

Förderung

  • National Science and Technology Major Project
  • Nanjing Medical University
  • National Natural Science Foundation of China

Zitieren

APA

Guo, W., Sun, Y., Yin, Y., Lin, F., Liu, D., Xu, J., Yu, C., Fu, Z., Gong, Y., Zhang, Q., & Zhou, H. (2026). Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study. Nutrition, Metabolism and Cardiovascular Diseases. https://doi.org/10.1016/j.numecd.2026.104850

Vancouver

Guo W, Sun Y, Yin Y, Lin F, Liu D, Xu J, et al. Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study. Nutrition, Metabolism and Cardiovascular Diseases. 2026. doi:10.1016/j.numecd.2026.104850

BibTeX
@article{Guo2026,
  author = {Guo, Wen and Sun, Yan and Yin, Yimin and Lin, Fei and Liu, Dan and Xu, Jin and Yu, Chengxiao and Fu, Zhenzhen and Gong, Yingyun and Zhang, Qun and Zhou, Hongwen},
  title = {Association of lipoprotein(a) and MASLD in predicting carotid atherosclerosis in asymptomatic individuals: a large scale cross-sectional and longitudinal study},
  journal = {Nutrition, Metabolism and Cardiovascular Diseases},
  year = {2026},
  doi = {10.1016/j.numecd.2026.104850}
}
Kostenlos starten →